Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Utah Medical Products (UTMD) EBT Margin (2016 - 2025)

Historic EBT Margin for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to 33.72%.

  • Utah Medical Products' EBT Margin fell 80500.0% to 33.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 37.84%, marking a year-over-year decrease of 34700.0%. This contributed to the annual value of 41.08% for FY2024, which is 10800.0% up from last year.
  • According to the latest figures from Q3 2025, Utah Medical Products' EBT Margin is 33.72%, which was down 80500.0% from 38.54% recorded in Q2 2025.
  • In the past 5 years, Utah Medical Products' EBT Margin ranged from a high of 42.31% in Q1 2024 and a low of 33.72% during Q3 2025
  • Its 5-year average for EBT Margin is 39.41%, with a median of 40.12% in 2021.
  • Its EBT Margin has fluctuated over the past 5 years, first surged by 157800bps in 2021, then tumbled by -80500bps in 2025.
  • Utah Medical Products' EBT Margin (Quarter) stood at 40.12% in 2021, then increased by 3bps to 41.19% in 2022, then decreased by -1bps to 40.68% in 2023, then decreased by -3bps to 39.47% in 2024, then dropped by -15bps to 33.72% in 2025.
  • Its EBT Margin stands at 33.72% for Q3 2025, versus 38.54% for Q2 2025 and 39.73% for Q1 2025.